Basolateral efflux mediated by multidrug resistance-associated protein 3 (Mrp3/Abcc3) facilitates intestinal absorption of folates in mouse

Pharmaceutical Research

Volumn 27, Issue 4, 2010, Pages 665-672

  Kitamura, Yoshiaki ^a   Kusuhara, Hiroyuki ^a   Sugiyama, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Abc transporters; Active transport; Intestinal absorption; M.RP3; Serosal efflux

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; CYANOCOBALAMIN; FOLIC ACID; FOLINIC ACID; HOMOCYSTEINE; MULTIDRUG RESISTANCE PROTEIN 3; 5-METHYLTETRAHYDROFOLATE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 3; TETRAHYDROFOLIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG METABOLISM; DRUG TRANSPORT; DUODENUM; IN VITRO STUDY; IN VIVO STUDY; INTESTINE ABSORPTION; MALE; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; TRANSPORT KINETICS; WILD TYPE; ANIMAL; BLOOD; GENE DELETION; GENETICS; METABOLISM;

ANIMALS; FOLIC ACID; GENE DELETION; HOMOCYSTEINE; INTESTINAL ABSORPTION; LEUCOVORIN; MALE; MICE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; TETRAHYDROFOLATES; VITAMIN B 12;

EID: 77953160743     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-0047-4     Document Type: Article

References (28)

1. Hirohashi T, Suzuki H, Ito K, Ogawa K, Kume K, Shimizu T, et al. Hepatic expression of multidrug resistance-associated proteinlike proteins maintained in eisai hyperbilirubinemic rats. Mol Pharmacol. 1998;53:1068-1075 (Pubitemid 28280450)
2. Zelcer N, van de Wetering K, de Waart R, Scheffer GL, Marschall HU, Wielinga PR, et al. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. J Hepatol. 2006;44:768-775
3. Donner MG, Keppler D. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. Hepatology. 2001;34:351-359 (Pubitemid 32702348)
4. Zelcer N, van de Wetering K, Hillebrand M, Sarton E, Kuil A, Wielinga PR, et ai Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proc Natl. Acad Sd USA. 2005;102:7274-7279
5. Scheffer GL, Kool M, Heijn M, de Haas M, Pijnenborg AC, Wijnholds J, et ai Specific detection of multidrug resistance proteins MRPl, MR.P2, MR.P3, MR.P5, and MDR.3 P-glycoprotein with, a panel of monoclonal antibodies. Cancer Res. 2000;60:5269-5277
6. Kusuhara H, Sugiyama Y. In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney. Drug Metab Pharmacokinet. 2009;24:37-52.
7. Kitamura Y, Hirouchi M, Kusuhara H, Schuetz JD, Sugiyama Y. Increasing systemic exposure of methotrexate by active efflux mediated by multidrug resistance-associated protein 3 (mrp3/ abcc3). J Pharmacol Exp Ther. 2008;327:465-473
8. Matsushima S, Maeda K, Hayashi H, Debori Y, Schinkel AH, Schuetz JD, et al. Involvement of multiple efflux transporters in hepatic disposition of fexofenadine. Mol Pharmacol. 2008;73:1474-1483 (Pubitemid 351574837)
9. Rost D, Mahner S, Sugiyama Y, Stremmel W. Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine. Am J Physiol Gastrointest Liver Physiol. 2002;282:G720-6. (Pubitemid 34651651)
10. Hirohashi T, Suzuki H, Takikawa H, Sugiyama Y. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). J Biol Chem. 2000;275:2905-2910 (Pubitemid 30082066)
11. Dawson PA, Hubbert M, Haywood J, Craddock AL, Zerangue N, Christian WV, et al. The heteromeric organic solute trans- porter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter. J Biol Chem. 2005;280:6960-6968 (Pubitemid 40341252)
12. Sakamoto S, Suzuki H, Kusuhara H, Sugiyama Y. Efflux mechanism, of taurocholate across the rat intestinal basolateral. membrane. Mol Pharm. 2006;3:275-281 (Pubitemid 44021433)
13. Zeng H, Chen ZS, Belinsky MG, Rea PA, Kruh GD. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1: effect of polyglutamylation on MTX transport. Cancer Res. 2001;61:7225-7232 (Pubitemid 32946519)
14. Liu. M, Ge Y, Cabelof DC, Aboukameel A, Heydari AR, Mohammad R, et al. Structure and regulation of the murine reduced, folate carrier gene: identification of four noncoding exons and promoters and regulation by dietary folates. J Biol Chem. 2005;280:5588-5597 (Pubitemid 40280037)
15. Qiu A, Jansen M, Sakaris A, Min SH, Chattopadhyay S, Tsai E, et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell. 2006;127:917-928 (Pubitemid 44792250)
16. Dudeja PK, Kode A, Alnounou M, Tyagi S, Torania S, Subramanian VS, et al Mechanism of folate transport across the human colonic basolateral membrane. Am J Physiol Gastrointest Liver Physiol. 2001;281:G54-60. (Pubitemid 32916495)
17. Said HM, Redha R. A carrier-mediated transport for folate in basolateral membrane vesicles of rat small intestine. Biochem J. 1987;247:141-146
18. Enokizono J, Kusuhara H, Sugiyama Y. Regional expression and activity of breast cancer resistance protein (Bcrp/Abcg2) in. mouse intestine: overlapping distribution with sulfotransferases. Drug Metab Dispos. 2007;35:922-928 (Pubitemid 46798603)
19. Brown RP, DeIp MD, Lindstedt SL, Rhomberg LR, Beliles RP. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health. 1997;13:407-484 (Pubitemid 27314117)
20. Kumar CK, Nguyen TT, Gonzales FB, Said HM. Comparison of intestinal folate carrier clone expressed in IEC-6 cells and in Xenopus oocytes. Am J Physiol. 1998;274:C289-94.
21. Nakai Y, Inoue K, Abe N, Hatakeyama M, Ohta KY, Otagiri M, et ai Functional characterization of human proton-coupled folate transporter/lieme carrier protein 1 heterologously expressed in mammalian cells as a folate transporter. J Pharmacol Exp Ther. 2007;322:469-476
22. Zhao R, Min SH, Qiu A, Sakaris A, Goldberg GL, Sandoval C, et al. The spectrum of mutations in the PCFT gene, coding for an. intestinal folate transporter, that are the basis for hereditary folate malabsorption. Blood. 2007;110:1147-1152 (Pubitemid 47281410)
23. Qiu A, Min SH, Jansen M, Malhotra U, Tsai E, Cabelof DC, et al. Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction. Am J Physiol Cell Physiol. 2007;293:C1669-78. (Pubitemid 350085626)
24. Ubbink JB, Vermaak WJ, van der Merwe A, Becker PJ, Delport R, Potgieter HC. Vitamin requirements for the treatment of hyperhomocysteinemia in. humans. J Nutr. 1994;124:1927-1933 (Pubitemid 24334627)
25. Ito K, Suzuki H, Horie T, Sugiyama Y. Apical/basolateral surface expression of drug transporters and its role in vectorial drug transport. Pharm Res. 2005;22:1559-1577 (Pubitemid 41355896)
26. Zamek-Gliszczynski MJ, Nezasa K, Tian X, Bridges AS, Lee K, Belinsky MG, et al. Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/and Abcc4-/- mice. J Pharmacol Exp Ther. 2006;319:1485-1491
27. Kitamura Y, Kusuhara H, Sugiyama Y. Functional characterization of multidrug resistance-associated protein 3 (Mrp3/ Abcc3) in the basolateral efflux of glucuronide conjugates in the mouse small intestine. J Pharmacol Exp Ther, in press.
28. Taipalensuu J, Tomblom H, Lindberg G, Einarsson C, Sjoqvist F, Meíhus H, et al. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther. 2001;299:164-170 (Pubitemid 32905131)